HuT 78 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF4512
Target Cell Organism: Human
Target Cell Name: HuT 78
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide HuT 78-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HuT 78
Target Cell Organism
Human
Target Cell Background
HuT 78 is a cutaneous T-lymphocyte cell line derived from a 53-year-old, White, male patient with Sezary Syndrome. This cell line can be used in immunology and immuno-oncology research.
Related Diseases
Sezary Syndrome
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry